[Atypical location of a malignant mesonephrogenic tumor. A case contribution to the nosology of female bladder neck obstruction].
PMID:
Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer.
Oh DY, Kwek SS, Raju SS, Li T, McCarthy E, Chow E, Aran D, Ilano A, Pai CS, Rancan C, Allaire K, Burra A, Sun Y, Spitzer MH, Mangul S, Porten S, Meng MV, Friedlander TW, Ye CJ, Fong L.
Cell. 2020 Jun 25;181(7):1612-1625.e13. doi: 10.1016/j.cell.2020.05.017. Epub 2020 Jun 3.
PMID:32497499
Bladder neck involvement in non-muscle-invasive bladder cancer: risk implications and outcomes of BCG vs gemcitabine/docetaxel.
Eraky A, Ben-David R, Hug B, Kolanukuduru KP, Tillu N, Wiklund P, Mehrazin R, Sfakianos JP.
BJU Int. 2025 Dec;136(6):1028-1036. doi: 10.1111/bju.16827. Epub 2025 Jun 15.
PMID:40518596
Editorial Comment to Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer.
Naselli A, Pirola GM.
Int J Urol. 2023 Apr;30(4):388-389. doi: 10.1111/iju.15150. Epub 2023 Jan 18.
PMID:36653186
Editorial Comment to Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer.
Liu Z, Leow JJ, Yong DZP.
Int J Urol. 2023 May;30(5):497. doi: 10.1111/iju.15200. Epub 2023 May 10.
PMID:37161584
Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer.
Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y.